SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 OrthoBio Market Recap.
Up 3.4% YoY, the OrthoBio market is off to a good start. Companies that are surpassing growth expectations tend to have differentiated products, focused efforts and incremental pull through from synergistic sales strategies. Market subtleties like reimbursement, pricing pressures and market loss due to newer competition continue to afflict some companies and segments...
Among the many topics covered in the full Q118 OrthoBio Market Recap are:
- No Big Surprises for the US Bone Replacement Market
- US Stem Cells Segment
- US Bone Growth Factors Segment
- US Synthetics Segment
- US Spinal Constructs
- A Solid Performance for the US Cartilage Replacement Market
- Soft Tissue Augmentation Continues to Propel the US Soft Tissue Replacement Segment
- Coverage and Pricing Damper US Joint Fluid Market
-
Impact On All Segments
Read entire Market Recap including news, data and analysis*...
*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
